dr peter attia semaglutide A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% 320 – AMA 64: New

Almustanyir, S., Alhabeeb, H

CHANGES TO INFORMATION : The Company may change any information contained on the Website at any time without notice

Cardiovasc Diabetol 20(1):236 Giugliano D, Scappaticcio L, Longo M et al (2021) GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs

If your follicles are brittle, damaged, and weak, your hair is more prone to breakage and falling out

Studies Compare Bariatric Surgery and GLP-1 Effectiveness In a landmark head-to-head study, researchers from NYU Langone Health compared over 51,000 patients on GLP-1 medications versus those who had bariatric surgery